The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Travel, Accommodations, Expenses - Merck Sharp & Dohme
Genomic determinants of response to pembrolizumab in head and neck squamous cell carcinoma (HNSCC).
 
Robert I. Haddad
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Celgene; Eisai; Merck; Pfizer
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Merck (Inst); VentiRx (Inst)
 
Tanguy Y. Seiwert
Honoraria - Merck
 
Laura Quan Man Chow
Honoraria - Amgen; Emergent BioSolutions; Novartis
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Emergent BioSolutions; genzyme; Merck; Novartis; pfizer; Seagen
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Incyte (Inst); Lilly/ImClone (Inst); Merck (Inst); NCCN/Glaxo-Smith Kline (Inst); Novartis (Inst); Pfizer (Inst); VentiRx (Inst)
 
Shilpa Gupta
Consulting or Advisory Role - Exelixis; Genentech; Merck
Speakers' Bureau - Bristol-Myers Squibb; Genentech; Pfizer
Research Funding - Astellas Medivation (Inst); Innocrin Pharma (Inst); MedImmune (Inst); Merck (Inst); Pfizer (Inst)
 
Jared Weiss
Consulting or Advisory Role - AstraZeneca; Biodesix; EMD Serono; Genentech; Lilly; OncoPlex Diagnostics
Research Funding - Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Celgene (Inst); Merck (Inst); novartis (Inst); Pfizer (Inst)
 
Iris Gluck
No Relationships to Disclose
 
Joseph Paul Eder
Honoraria - Merck; Nektar
Research Funding - AstraZeneca (Inst)
 
Barbara Burtness
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Debiopharm Group; MedImmune; Merck; VentiRx
Research Funding - Merck
 
Makoto Tahara
Honoraria - Bayer; Bristol-Myers Squibb; Eisai; Merck Serono; Takeda
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Ono Pharmaceutical; Pfizer
Research Funding - AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Eisai (Inst); Merck Sharp & Dohme (Inst); NanoCarrier (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst)
 
Bhumsuk Keam
No Relationships to Disclose
 
Hyunseok Kang
No Relationships to Disclose
 
Kei Muro
Honoraria - Chugai Pharma; Lilly; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Andrew Albright
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Lingkang Huang
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Mark Ayers
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Robin Mogg
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Razvan Cristescu
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Jonathan D. Cheng
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Ranee Mehra
Employment - GlaxoSmithKline (I)
Stock and Other Ownership Interests - GlaxoSmithKline (I)
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Genentech; Innate Pharma; Novartis
Research Funding - Genentech
Travel, Accommodations, Expenses - Mirati Therapeutics